Qingdao Haier Biomedical Co Ltd (688139) — Cash Flow-to-Debt Ratio
Qingdao Haier Biomedical Co Ltd (688139) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2023, meaning its operating cash flow of CN¥7.33 Million could theoretically repay 0% of its total liabilities (CN¥1.15 Billion) in one year. See 688139 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Qingdao Haier Biomedical Co Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Qingdao Haier Biomedical Co Ltd across 10 annual periods. For the full cash flow conversion analysis, see Qingdao Haier Biomedical Co Ltd cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Qingdao Haier Biomedical Co Ltd (2016–2025)
Year-by-year debt coverage analysis for Qingdao Haier Biomedical Co Ltd. Check Qingdao Haier Biomedical Co Ltd (688139) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | CN¥267.89 Million | CN¥1.17 Billion | ▼ -8.1% |
| 2024 | 0.25x | CN¥291.67 Million | CN¥1.17 Billion | ▲ +8.6% |
| 2023 | 0.23x | CN¥249.26 Million | CN¥1.09 Billion | ▼ -51.3% |
| 2022 | 0.47x | CN¥632.43 Million | CN¥1.34 Billion | ▼ -5.9% |
| 2021 | 0.50x | CN¥632.43 Million | CN¥1.26 Billion | ▼ -16.6% |
| 2020 | 0.60x | CN¥696.62 Million | CN¥1.16 Billion | ▲ +24.6% |
| 2019 | 0.48x | CN¥280.49 Million | CN¥581.08 Million | ▲ +260.9% |
| 2018 | 0.13x | CN¥149.00 Million | CN¥1.11 Billion | ▼ -48.1% |
| 2017 | 0.26x | CN¥148.32 Million | CN¥575.92 Million | ▼ -73.6% |
| 2016 | 0.97x | CN¥220.72 Million | CN¥226.46 Million | — |